The statement presents factual information regarding the influence of corporate lobbyists on Congress members and the acceptance of money from pharmaceutical companies. It is a direct response to a question about drug pricing disparities, suggesting a systemic issue with lobbying and campaign finance.
Principle 1:
I will strive to do no harm with my words and actions.The statement does not appear to harm with words or actions, as it presents information relevant to the public interest.
[+1]Principle 4:
I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.The statement engages in constructive criticism by highlighting the potential impact of lobbying on drug pricing policies.
[+1]Principle 6:
I will use my influence for the betterment of society.The statement uses influence to inform and potentially better society by shedding light on a significant issue affecting drug prices.
[+1]